Nurix Therapeutics, Inc., a clinical stage biopharmaceutical company, focuses on the discovery, development, and commercialization of small molecule and antibody therapies for the treatment of cancer, inflammatory conditions, and other diseases. The company develops NX-5948, an orally bioavailable...
194 insider sale filings on record · latest filing 2026-10-15.
No open-market insider purchases (SEC Form 4 code P) on record for NRIX.